Incyte Corp - Company Profile
Powered by 
All the sales intelligence you need on Incyte Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Incyte Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Incyte Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Incyte Corp’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Incyte Corp's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
William J. Meury
Chief Executive Officer; Director Executive BoardMr. Bill Meury has been the President, Director and Chief Executive Officer of the company since June 2025. Previously, he served as the President and Chief Executive Officer of Anthos Therapeutics from April 2024 to April 2025. Prior to this, he served as the Chief Executive Officer of Karuna from 2023 to 2024. Earlier, he served as the served as a Partner at Hildred Capital Management from May 2020 to 2022 Previously, he served as the Chief Commercial Officer of Allergan from May 2016 to May 2020. He also served as President, Branded Pharma from March 2015 to May 2016 of Allergan and Executive Vice President, Commercial, North American Brands from 2014 to 2015. Meury also served as Executive Vice President, Sales and Marketing at Forest Laboratories.
Suketu Upadhyay
Executive Vice President; Chief Financial Officer Senior ManagementMr. Suketu Upadhyay has been the Executive Vice President and Chief Financial Officer of the company since May 2026. Previously, he was the Executive Vice President and Chief Financial Officer at Zimmer Biomet. Prior to this, he served as Senior Vice President of Global Financial Operations at Bristol Myers Squibb. Prior to that, he served as Executive Vice President and Chief Financial Officer at Endo International. He also served as Interim Chief Financial Officer and Chief Accounting Officer at Becton Dickinson. Earlier, Mr. Upadhyay worked at AstraZeneca and Johnson & Johnson.
David Gardner
Executive Vice President; Chief Strategy Officer Senior ManagementMr. Dave Gardner has been the Executive Vice President and Chief Strategy Officer of the company since September 2025. Previously, he was the Vice President and Equity Research Analyst at BlackRock. Prior to this, he worked at Rock Springs Capital Management from May 2015 to September 2025. Earlier, he served as the Vice President and Equity Research Analyst of BlackRock.
Steven H. Stein
Executive Vice President; Chief Medical Officer; Head - Late-stage Development Senior ManagementDr. Steven H. Stein has been the Executive Vice President, Chief Medical Officer and Head of Advanced Clinical Development of the company since 2026. Prior to this, he served as the Senior Vice President, US Clinical Development & Medical Affairs at Novartis Oncology US. Previously, he served as the Vice President of Global Oncology, Clinical Development and Head of Medicines Development for Hematology and Supportive Care at GlaxoSmithKline.
Soni Basi
Executive Vice President; Chief Human Resources Officer Senior ManagementMs. Soni Basi has been the Executive Vice President and Chief Human Resources Officer of the company since August 2025. Earlier, he served as the Professional Consulting Services through SKB People Advisory from June 2024 to August 2025. Prior to this, she served as the Chief Human Resources Officer at Edelman from May 2022 to May 2024. He also served as Head of Global Talent Management at American International Group from August 2020 to April 2022.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer